Testing effectiveness (Phase 2)Study completedNCT01576380
What this trial is testing
A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients
Who this might be right for
Adenocarcinoma, ScirrhousLinitis PlasticaStomach Neoplasms+3 more
Novartis Pharmaceuticals 11